BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33164665)

  • 1. Pharmacokinetics and Pharmacodynamics of Antimicrobial Agents in Burn Patients.
    Pruskowski KA
    Surg Infect (Larchmt); 2021 Feb; 22(1):77-82. PubMed ID: 33164665
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous Antibiotic and Antifungal Agent Pharmacokinetic-Pharmacodynamic Dosing in Adults with Severe Burn Injury.
    Cota JM; FakhriRavari A; Rowan MP; Chung KK; Murray CK; Akers KS
    Clin Ther; 2016 Sep; 38(9):2016-31. PubMed ID: 27586127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antimicrobial treatment in burn injury patients].
    Trupkovic T; Gille J; Fischer H; Kleinschmidt S
    Anaesthesist; 2012 Mar; 61(3):249-51, 254-6, 258. PubMed ID: 22430556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of antibacterial and antifungal agents in adult patients with thermal injury: a review of current literature.
    Ortwine JK; Pogue JM; Faris J
    J Burn Care Res; 2015; 36(2):e72-84. PubMed ID: 25167375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.
    Roberts JK; Stockmann C; Constance JE; Stiers J; Spigarelli MG; Ward RM; Sherwin CM
    Clin Pharmacokinet; 2014 Jul; 53(7):581-610. PubMed ID: 24871768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gap analysis of pharmacokinetics and pharmacodynamics in burn patients: a review.
    Steele AN; Grimsrud KN; Sen S; Palmieri TL; Greenhalgh DG; Tran NK
    J Burn Care Res; 2015; 36(3):e194-211. PubMed ID: 25942648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic considerations in antimicrobial therapy for sepsis.
    Fujii M; Karumai T; Yamamoto R; Kobayashi E; Ogawa K; Tounai M; Lipman J; Hayashi Y
    Expert Opin Drug Metab Toxicol; 2020 May; 16(5):415-430. PubMed ID: 32238005
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients.
    Blanchet B; Jullien V; Vinsonneau C; Tod M
    Clin Pharmacokinet; 2008; 47(10):635-54. PubMed ID: 18783295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infections in critically ill burn patients.
    Hidalgo F; Mas D; Rubio M; Garcia-Hierro P
    Med Intensiva; 2016 Apr; 40(3):179-85. PubMed ID: 27013315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updated antimicrobial dosing recommendations for obese patients.
    Castro-Balado A; Varela-Rey I; Mejuto B; Mondelo-García C; Zarra-Ferro I; Rodríguez-Jato T; Fernández-Ferreiro A
    Antimicrob Agents Chemother; 2024 May; 68(5):e0171923. PubMed ID: 38526051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational Selection and Use of Antimicrobials in Patients with Burn Injuries.
    Hill DM; Sinclair SE; Hickerson WL
    Clin Plast Surg; 2017 Jul; 44(3):521-534. PubMed ID: 28576241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical Antimicrobial Agents for Burn Wound Care: History and Current Status.
    Cancio LC
    Surg Infect (Larchmt); 2021 Feb; 22(1):3-11. PubMed ID: 33124942
    [No Abstract]   [Full Text] [Related]  

  • 13. Profile of infections and antimicrobial treatment among burn-injury patients.
    Sakabe D; Del Fiol Fde S
    Am J Infect Control; 2016 Aug; 44(8):950-2. PubMed ID: 27324611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of antibiotics in burn patients.
    Weinbren MJ
    J Antimicrob Chemother; 1999 Sep; 44(3):319-27. PubMed ID: 10511398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The basic principles of the antibiotic therapy of burn patients].
    Leseva M; Khadzhiĭski O; Grigorov G; Dimitrova A
    Khirurgiia (Sofiia); 1995; 48(3):8-11. PubMed ID: 8667589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study evaluating tobramycin pharmacokinetics and optimal once daily dosing in burn patients.
    Lee C; Walker SAN; Walker SE; Seto W; Simor A; Jeschke M
    Burns; 2017 Dec; 43(8):1766-1774. PubMed ID: 28647460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics in patients with burns.
    Jaehde U; Sörgel F
    Clin Pharmacokinet; 1995 Jul; 29(1):15-28. PubMed ID: 7586895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amikacin population pharmacokinetics among paediatric burn patients.
    Sherwin CM; Wead S; Stockmann C; Healy D; Spigarelli MG; Neely A; Kagan R
    Burns; 2014 Mar; 40(2):311-8. PubMed ID: 23876785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical antimicrobials in pediatric burn wound management.
    Patel PP; Vasquez SA; Granick MS; Rhee ST
    J Craniofac Surg; 2008 Jul; 19(4):913-22. PubMed ID: 18650712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Outcome and Antimicrobial Therapeutic Drug Monitoring for the Treatment of Infections in Acute Burn Patients.
    Machado AS; Oliveira MS; Sanches C; Silva Junior CVD; Gomez DS; Gemperli R; Santos SRCJ; Levin AS
    Clin Ther; 2017 Aug; 39(8):1649-1657.e3. PubMed ID: 28705450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.